350 related articles for article (PubMed ID: 10583412)
21. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
[TBL] [Abstract][Full Text] [Related]
22. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
[TBL] [Abstract][Full Text] [Related]
23. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
[TBL] [Abstract][Full Text] [Related]
24. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
del Rincón SV; Rousseau C; Samanta R; Miller WH
Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186
[TBL] [Abstract][Full Text] [Related]
26. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells.
del Aguila LF; Claffey KP; Kirwan JP
Am J Physiol; 1999 May; 276(5):E849-55. PubMed ID: 10329978
[TBL] [Abstract][Full Text] [Related]
27. The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts.
Takata Y; Imamura T; Haruta T; Sasaoka T; Morioka H; Ishihara H; Sawa T; Usui I; Ishiki M; Kobayashi M
Metabolism; 1996 Dec; 45(12):1474-82. PubMed ID: 8969279
[TBL] [Abstract][Full Text] [Related]
28. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
[TBL] [Abstract][Full Text] [Related]
29. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.
Rui L; Fisher TL; Thomas J; White MF
J Biol Chem; 2001 Oct; 276(43):40362-7. PubMed ID: 11546773
[TBL] [Abstract][Full Text] [Related]
30. Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905.
Li S; Zhang H; Hoff H; Sell C
Exp Cell Res; 1998 Sep; 243(2):326-33. PubMed ID: 9743592
[TBL] [Abstract][Full Text] [Related]
31. TNF-alpha stimulates glucose uptake in L6 myoblasts.
Yamasaki H; Yamaguchi Y; Takino H; Matsuo H; Matsumoto K; Uotani S; Akazawa S; Yamashita S; Nagataki S
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):11-8. PubMed ID: 8803477
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of insulin-like growth factor-1 receptor and IRS-2 signaling by ethanol in SH-SY5Y neuroblastoma cells.
Seiler AE; Ross BN; Rubin R
J Neurochem; 2001 Jan; 76(2):573-81. PubMed ID: 11208920
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
[TBL] [Abstract][Full Text] [Related]
35. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
36. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.
Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL
Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059
[TBL] [Abstract][Full Text] [Related]
37. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells.
Amoui M; Craddock BP; Miller WT
J Endocrinol; 2001 Oct; 171(1):153-62. PubMed ID: 11572799
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
39. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
Weng LP; Smith WM; Brown JL; Eng C
Hum Mol Genet; 2001 Mar; 10(6):605-16. PubMed ID: 11230180
[TBL] [Abstract][Full Text] [Related]
40. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
